SZ 162 (Ropinirole hydrochloride extended-release 12 mg)

Pill imprint SZ 162 has been identified as Ropinirole hydrochloride extended-release 12 mg.

Ropinirole is used in the treatment of parkinson's disease; restless legs syndrome; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 12 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ropinirole hydrochloride extended-release

Imprint:

SZ 162

Strength:

12 mg

Color:

Green

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Dopaminergic antiparkinsonism agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Sandoz Inc.

National Drug Code (NDC):

00781-5788

Inactive Ingredients:

carboxymethylcellulose sodium
silicon dioxide
hydrogenated castor oil
hydroxypropyl cellulose
hypromelloses
lactose anhydrous
magnesium stearate
magnesium silicate
polyethylene glycol
ferrosoferric oxide
polysorbate 80
titanium dioxide
diethyl phthalate
maltodextrin
ferric oxide yellow
FD&C Blue No. 2
ethylcelluloses

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.